BRIEF-Chemours FY Adjusted EPS USD 1.21 Vs. IBES Estimate USD 1.22

Reuters
Feb 18, 2025
BRIEF-Chemours FY Adjusted EPS USD 1.21 Vs. IBES Estimate USD 1.22

Feb 18 (Reuters) - Chemours FY adjusted EBITDA USD 786 million vs. IBES estimate USD 772.8 million.

  • FY adjusted net income USD 182 million vs. IBES estimate USD 181.8 million
  • FY sales USD 5,800 million vs. IBES estimate USD 5,759 million

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10